NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
Go back to NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy| (NASDAQ: AKRO) | Delayed: 54.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.74 | 52 Week High | $ | |||
| Open | $54.74 | 52 Week Low | $ | |||
| Day High | $54.74 | P/E | N/A | |||
| Day Low | $54.74 | EPS | $ | |||
| Volume | 3,745,691 | |||||
| (NASDAQ: NXTC) | Delayed: 4.18 -0.22 (5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.40 | 52 Week High | $ | |||
| Open | $4.30 | 52 Week Low | $ | |||
| Day High | $4.62 | P/E | N/A | |||
| Day Low | $4.10 | EPS | $ | |||
| Volume | 252,642 | |||||
